Vectors derived from the autonomous parvovirus Minute virus of mice, MVM(p), are promising tools for the gene therapy of cancer. The validation of their in vivo anti-tumour effect is, however, hampered by the difficulty to produce high-titre stocks. In an attempt to increase vector titres, host cells were subjected to low oxygen tension (hypoxia). It has been shown that a number of viruses are produced at higher titres under these conditions. This is the case, among others, for another member of the family Parvoviridae, the erythrovirus B19 virus. Hypoxia stabilizes a hypoxia-inducible transcription factor (HIF-1α) that interacts with a ‘hypoxia-responsive element’ (HRE), the consensus sequence of which (A/GCGTG) is present in the B19 and MVM promoters. Whilst the native P4 promoter was induced weakly in hypoxia, vector production was reduced dramatically, and adding HRE elements to the P4 promoter of the vector did not alleviate this reduction. Hypoxia has many effects on cell metabolism. Therefore, even if the P4 promoter is activated, the cellular factors that are required for the completion of the parvoviral life cycle may not be expressed.
AstellC. R.,
GardinerE. M.,
TattersallP.1986; DNA sequence of the lymphotropic variant of minute virus of mice, MVM(i), and comparison with the DNA sequence of the fibrotropic prototype strain. J Virol 57:656–669
BrandenburgerA.,
VeluT.2004; Autonomous parvovirus vectors : preventing the generation of wild-type or replication-competent virus. J Gene Med 6:S203–S211[CrossRef]
Caillet-FauquetP.,
PerrosM.,
BrandenburgerA.,
SpegelaereP.,
RommelaereJ.1990; Programmed killing of human cells by means of an inducible clone of parvoviral genes encoding non-structural proteins. EMBO J 9:2989–2995
CheongS. C.,
ClémentN.,
VeluT.,
BrandenburgerA.2003; A novel method for the titration of recombinant virus stocks by ELISPOT assay. J Virol Methods 109:119–124[CrossRef]
ClémentN.,
VeluT.,
BrandenburgerA.2002; Construction and production of oncotropic vectors, derived from MVM(p), that share reduced sequence homology with helper plasmids. Cancer Gene Ther 9:762–770[CrossRef]
CotmoreS. F.,
SturzenbeckerL. J.,
TattersallP.1983; The autonomous parvovirus MVM encodes two nonstructural proteins in addition to its capsid polypeptides. Virology 129:333–343[CrossRef]
EbbesenP.,
TothF. D.,
VilladsenJ. A.,
Norskov-LauritsenN.1991; In vitro interferon and virus production at in vivo physiologic oxygen tensions. In Vivo 5:355–358
HuangL. E.,
AranyZ.,
LivingstonD. M.,
BunnH. F.1996; Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its α subunit. J Biol Chem 271:32253–32259[CrossRef]
MottetD.,
MichelG.,
RenardP.,
NinaneN.,
RaesM.,
MichielsC.2003; Role of ERK and calcium in the hypoxia-induced activation of HIF-1. J Cell Physiol 194:30–44[CrossRef]
NüeschJ. P. F.,
DettwilerS.,
CorbeauR.,
RommelaereJ.1998; Replicative functions of minute virus of mice NS1 protein are regulated in vitro by phosphorylation through protein kinase C. J Virol 72:9966–9977
RiedingerH.-J.,
van BetteraeyM.,
ProbstH.1999; Hypoxia blocks in vivo initiation of simian virus 40 replication at a stage preceding origin unwinding. J Virol 73:2243–2252
RuanH.,
SuH.,
HuL.,
LambornK. R.,
KanY. W.,
DeenD. F.2001; A hypoxia-regulated adeno-associated virus vector for cancer-specific gene therapy. Neoplasia 3:255–263[CrossRef]
WangD.,
RuanH.,
HuL.,
LambornK. R.,
KongE. L.,
RehemtullaA.,
DeenD. F.2005; Development of a hypoxia-inducible cytosine deaminase expression vector for gene-directed prodrug cancer therapy. Cancer Gene Ther 12:276–283[CrossRef]